Search

everythinglearnresearchcommunity

for

Search:↓

Systemic corticosteroids might help treat hair loss caused by alemtuzumab in MS patients.

Alopecia areata can be an early sign of Hodgkin’s lymphoma and may improve with lymphoma treatment.

Denosumab treatment for osteoporosis can cause hair loss.

The document concludes that various hair and scalp disorders in children have specific treatments and proper diagnosis is essential.

High levels of IL6 and CRP, and low levels of vitamin D, might be indicators of alopecia areata.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

People with severe hair loss (Alopecia Areata) have different scalp bacteria than healthy people, which might help predict the condition's progress.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

AIRE deficiency causes hair loss similar to alopecia areata in mice.

Activated and non-activated PRP are equally safe and effective for treating alopecia areata.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Lupus erythematosus can mimic alopecia areata, and trichoscopy is key for accurate diagnosis and better patient outcomes.

Candida antigen is an effective and promising treatment for alopecia areata.

Baricitinib is effective for severe alopecia areata but has some side effects.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

Betamethasone dipropionate lotion is more effective than minoxidil solution for treating Alopecia Areata.

Covid-19 can cause hair loss due to immune and psychological factors.

Alopecia Areata affects people of all ages worldwide, is likely caused by genetic and environmental factors, and can lead to stress and depression, highlighting the need for treatments that address both physical and mental health.

Alopecia Areata is linked to a higher risk of several diseases, which vary with age and sex.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Six genetic conditions are often linked to complete scalp hair loss in children.

During the COVID-19 pandemic, some skin conditions became more common while others decreased.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The Sinclair Shedding Scale is effective for diagnosing Alopecia Areata Incognita and monitoring treatment success.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

Narrowband UVB phototherapy alone is not very effective for treating alopecia areata.